Baktisubtil

General characteristics. Structure:

Active agent: lyophilicly dried up V.'s disputes of cereus IP 5832 (the 109th dispute) - 35 mg.

Excipients: a) calcium carbonate - 25 mg) a kaolin - 100 mg.

Structure of a cover of the capsule: titanium dioxide (E 171), gelatin.

Pharmacological properties:

V.'s bacteria of cereus IP 5832 emit the antibacterial substances of a broad spectrum of activity which are suppressing development of pathogenic and conditionally pathogenic bacteriums, having antimicrobic, antidiarrheal effect, recovers intestinal microflora. The disputes of bacteria which are contained in drug are steady against action of a gastric juice. Their germination in vegetative forms of bacteria happens in intestines.

Indications to use:

- acute and chronic diarrhea of various genesis;

- intestinal dysbacteriosis (especially owing to treatment by antibiotics of a broad spectrum of activity);

- prevention and treatment of the dysfunctions of intestines provoked himio-or radiotheraphy.

Route of administration and doses:

It is necessary to accept Baktisubtil in 1 hour prior to food.

In cases of difficulties with reception, contents of the capsule are poured out in a glass with cold or warmish liquid.

It is impossible to wash down Baktisubtil with hot drink or to accept it with alcoholic beverages.

Attention! Drug is appointed individually for each patient. It is not necessary to accept drug uncontrolledly or on the advice of the third parties.

In order to avoid undesirable interaction of drug with other medicines it is necessary to tell the attending physician or the pharmacist about in parallel the accepted medicines. If at treatment improvement does not occur within 2 days, it is necessary to report about it to the attending physician.

Dosage:

- to children 3 years on 3-6 capsules a day within 7-10 days are more senior;

- to teenagers and adults on 4-8 capsules a day within 7-10 days.

Features of use:

Baktisubtil is applied on doctor's orders, being appointed individually for each patient, it is not necessary to accept drug uncontrolledly or on the advice of the third parties.

If at treatment diarrhea does not stop more than two days, drug should be cancelled.

Side effects:

At use of drug according to indications in the recommended doses side effect is not revealed.

Interaction with other medicines:

Baktisubtil резистентен to action of various antibiotics and sulfanamide drugs therefore it can be appointed together with the last.

Contraindications:

Obviously known hypersensitivity to any of drug components Baktisubtil.

Primary immunodeficiences.

Storage conditions:

In the dry, protected from light place, at a temperature not above 25 °C.

To store in the place, unavailable to children.

Issue conditions:

According to the recipe

Packaging:

The blister packaging on 20 capsules. In a cardboard pack on 20 capsules (1 blister) together with the application instruction.